Search Results - "Ilyas, Sumera"

Emerging Molecular Therapeutic Targets for Cholangiocarcinoma by Rizvi, Sumera, Gores, Gregory J

“…Abstract Cholangiocarcinomas (CCAs) are diverse epithelial tumors arising from the liver or large bile ducts with features of cholangiocyte differentiation,…”
Get full text

Cholangiocarcinoma — evolving concepts and therapeutic strategies by Ilyas, Sumera I., Khan, Shahid A., Hallemeier, Christopher L., Kelley, Robin K., Gores, Gregory J.

“…Key Points Each anatomical subtype of cholangiocarcinoma, intrahepatic (iCCA), perihilar (pCCA) and distal (dCCA), has a distinct epidemiology, biology, and…”
Get full text

Liver Cancer Immunity by Rizvi, Sumera, Wang, Juan, El‐Khoueiry, Anthony B.

Get full text

Cholangiocarcinoma — novel biological insights and therapeutic strategies by Ilyas, Sumera I., Affo, Silvia, Goyal, Lipika, Lamarca, Angela, Sapisochin, Gonzalo, Yang, Ju Dong, Gores, Gregory J.

“…In the past 5 years, important advances have been made in the scientific understanding and clinical management of cholangiocarcinoma (CCA). The cellular immune…”
Get full text

S2726 A Rare Ca(u)se of Metastatic Renal Cell Carcinoma in the Biliary Tree by Pisipati, Sailaja, Ilyas, Sumera, Bofill-Garcia, Aliana

Get full text

Immunobiology of cholangiocarcinoma by Tomlinson, Jennifer L., Valle, Juan W., Ilyas, Sumera I.

“…Recent literature has significantly advanced our knowledge and understanding of the tumour immune microenvironment of cholangiocarcinoma. Detailed…”
Get full text

EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma by Alvaro, Domenico, Gores, Gregory J., Walicki, Joël, Hassan, Cesare, Sapisochin, Gonzalo, Komuta, Mina, Forner, Alejandro, Valle, Juan W., Laghi, Andrea, Ilyas, Sumera I., Park, Joong-Won, Kelley, Robin K., Reig, Maria, Sangro, Bruno

“…Intrahepatic cholangiocarcinoma (iCCA) develops inside the liver, between bile ductules and the second-order bile ducts. It is the second most frequent primary…”
Get full text

Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma by Loeuillard, Emilien, Yang, Jingchun, Buckarma, EeeLN, Wang, Juan, Liu, Yuanhang, Conboy, Caitlin, Pavelko, Kevin D, Li, Ying, O'Brien, Daniel, Wang, Chen, Graham, Rondell P, Smoot, Rory L, Dong, Haidong, Ilyas, Sumera

“…Immune checkpoint blockade (ICB) has revolutionized cancer therapeutics. Desmoplastic malignancies, such as cholangiocarcinoma (CCA), have an abundant tumor…”
Get full text

Targeting cholangiocarcinoma by Mertens, Joachim C., Rizvi, Sumera, Gores, Gregory J.

“…Cholangiocarcinoma (CCA) represents a diverse group of epithelial cancers associated with the biliary tract, and can best be stratified anatomically into…”
Get full text

Cholangiocarcinoma by Brindley, Paul J., Bachini, Melinda, Ilyas, Sumera I., Khan, Shahid A., Loukas, Alex, Sirica, Alphonse E., Teh, Bin Tean, Wongkham, Sopit, Gores, Gregory J.

“…Cholangiocarcinoma (CCA) is a highly lethal adenocarcinoma of the hepatobiliary system, which can be classified as intrahepatic, perihilar and distal. Each…”
Get full text

AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma by Bowlus, Christopher L, Arrivé, Lionel, Bergquist, Annika, Deneau, Mark, Forman, Lisa, Ilyas, Sumera I, Lunsford, Keri E, Martinez, Mercedes, Sapisochin, Gonzalo, Shroff, Rachna, Tabibian, James H, Assis, David N

Get full text

Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management by Rizvi, Sumera, Eaton, John E, Gores, Gregory J

“…Primary sclerosing cholangitis (PSC) is a premalignant biliary tract disease that confers a significant risk for the development of cholangiocarcinoma (CCA)…”
Get full text

Animal models of cholangiocarcinoma by Loeuillard, Emilien, Fischbach, Samantha R., Gores, Gregory J., Ilyas, Sumera I.

“…Cholangiocarcinoma (CCA) is an aggressive biliary tract malignancy with a poor overall prognosis. There is a critical need to develop effective targeted…”
Get full text

Transplant oncology in locally advanced intrahepatic cholangiocarcinoma: One more step on a long road by Ivanics, Tommy, Toso, Christian, Ilyas, Sumera I., Sapisochin, Gonzalo

“…An analysis by McMillan et al. (page 823) of patients with locally‐advanced unresectable intrahepatic cholangiocarcinoma following liver transplantation shows…”
Get full text

Cholangiocarcinoma: molecular pathways and therapeutic opportunities by I Ilyas, Sumera, Borad, Mitesh J, Patel, Tushar, Gores, Gregory J

“…Cholangiocarcinoma (CCA) is an aggressive biliary tract malignancy with limited treatment options and low survival rates. Currently, there are no curative…”
Get more information

Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma by Rizvi, Sumera, Gores, Gregory J

“…Cholangiocarcinomas (CCAs) are hepatobiliary cancers with features of cholangiocyte differentiation; they can be classified anatomically as intrahepatic CCA…”
Get full text

Hepatology Highlights by Penrice, Daniel D., Tomlinson, Jennifer, Watkins, Ryan, Ayares, Gustavo, Arab, Juan Pablo, Ilyas, Sumera I.

Get full text

IL‐33 facilitates oncogene‐induced cholangiocarcinoma in mice by an interleukin‐6‐sensitive mechanism by Yamada, Daisaku, Rizvi, Sumera, Razumilava, Nataliya, Bronk, Steven F., Davila, Jaime I., Champion, Mia D., Borad, Mitesh J., Bezerra, Jorge A., Chen, Xin, Gores, Gregory J.

“…Cholangiocarcinoma (CCA) is a lethal hepatobiliary neoplasm originating from the biliary apparatus. In humans, CCA risk factors include hepatobiliary…”
Get full text

Hepatology highlights by Conboy, Caitlin B., Penrice, Daniel D., Watkins, Ryan, Díaz, Luis Antonio, Arab, Juan Pablo, Ilyas, Sumera I.

Get full text

Hepatology highlights by Wu, Tiffany, Povero, Davide, Parthasarathy, Gopanandan, Idalsoaga, Francisco, Arab, Juan Pablo, Ilyas, Sumera I.

Get full text